Marinobufagenin Inhibits Neutrophil Migration and Proinflammatory Cytokines
Deyse C. M. Carvalho,Luiz Henrique Agra Cavalcante-Silva,Éssia de A. Lima,José G. F. M. Galvão,Anne K. de A. Alves,Priscilla R. O. Feijó,Luís E. M. Quintas,Sandra Rodrigues-Mascarenhas
DOI: https://doi.org/10.1155/2019/1094520
IF: 4.4929
2019-05-20
Journal of Immunology Research
Abstract:Cardiotonic steroids, such as ouabain and digoxin, are known to bind to Na + /K + -ATPase and to promote several biological activities, including anti-inflammatory activity. However, there are still no reports in the literature about inflammation and marinobufagenin, a cardiotonic steroid from the bufadienolide family endogenously found in mammals. Therefore, the aim of this work was to analyze, in vivo and in vitro , the role of marinobufagenin in acute inflammation. Swiss mice were treated with 0.56 mg/kg of marinobufagenin intraperitoneally (i.p.) and zymosan (2 mg/mL, i.p.) was used to induce peritoneal inflammation. Peritoneal fluid was collected and used for counting cells by optical microscopy and proinflammatory cytokine quantification (IL-1 β , IL-6, and TNF- α ) by immunoenzymatic assay (ELISA). Zymosan stimulation, as expected, induced increased cell migration and proinflammatory cytokine levels in the peritoneum. Marinobufagenin treatment reduced polymorphonuclear cell migration and IL-1 β and IL-6 levels in the peritoneal cavity, without interfering in TNF- α levels. In addition, the effect of marinobufagenin was evaluated using peritoneal macrophages stimulated by zymosan (0.2 mg/mL) in vitro . Marinobufagenin treatment at different concentrations (10, 100, 1000, and 10000 nM) showed no cytotoxic effect on peritoneal macrophages. Interestingly, the lowest concentration, which did not inhibit Na + /K + -ATPase activity, attenuated proinflammatory cytokines IL-1 β , IL-6, and TNF- α levels. To investigate the putative mechanism of action of marinobufagenin, the expression of surface molecules (TLR2 and CD69) and P-p38 MAPK were also evaluated, but no significant effect was observed. Thus, our results suggest that marinobufagenin has an anti-inflammatory role in vivo and in vitro and reveals a novel possible endogenous function of this steroid in mammals.
immunology